Abstract
Prenatal ultrasonography of a pregnant woman with a past history of total thyroidectomy for Graves’ disease detected fetal tachycardia, fetal growth restriction and oligohydramnios at 30 weeks gestation. Because a high titer of thyroid-stimulating hormone receptor antibody was noted in maternal serum and the fetal goiter was detected on ultrasonography, fetal hyperthyroidism was strongly suspected and subsequently confirmed with cordocentesis at 31 weeks gestation. After treatment of fetal hyperthyroidism through oral maternal administration of methimazole (MMI) starting at 33 weeks gestation, fetal heart rate and amniotic fluid volume returned to normal ranges. Complete resolution of the fetal goiter was observed at 35 weeks gestation. A male infant was born at 35 weeks 6 days gestation via cesarean section in the absence of thyrotoxic findings; however, cord blood chemical analysis at birth indicated iatrogenic fetal hypothyroidism. In the present report, maternal therapy using MMI to resolve symptoms of fetal thyrotoxicosis, including fetal tachycardia and oligohydramnios, was successfully conducted.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zimmerman D . Fetal and neonatal hyperthyroidism. Thyroid 1999; 9 (7): 727–733.
Polak M, Van Vliet G . Therapeutic approach of fetal thyroid disorders. Horm Res Paediatr 2010; 74 (1): 1–5.
Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J . Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009; 160 (1): 1–8.
Moore TR, Cayle JE . The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol 1990; 162 (5): 1168–1173.
Ranzini AC, Ananth CV, Smulian JC, Kung M, Limbachia A, Vintzileos AM . Ultrasonography of the fetal thyroid: nomograms based on biparietal diameter and gestational age. J Ultrasound Med 2001; 20 (6): 613–617.
Spremovic-Radjenovic S, Gudovic A, Lazovic G, Marinkovic J, Radunovic N, Ljubic A . Fetal free thyroxine concentrations in pregnant women with autoimmune thyroid disease. J Clin Endocrinol Metab 2012; 97 (11): 4014–4021.
Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21 (10): 1081–1125.
Guibourdenche J, Noel M, Chevenne D, Vuillard E, Volumenie JL, Polak M, et al. Biochemical investigation of foetal and neonatal thyroid function using the ACS-180SE analyser: clinical application. Ann Clin Biochem 2001; 38 (Part 5): 520–526.
Zakarija M, McKenzie JM, Hoffman WH . Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. J Clin Endocrinol Metab 1986; 62 (2): 368–371.
Luton D, Le Gac I, Vuillard E, Castanet M, Guibourdenche J, Noel M, et al. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 2005; 90 (11): 6093–6098.
Aslam M, Inayat M . Fetal and neonatal Graves disease: a case report and review of the literature. South Med J 2008; 101 (8): 840–841.
Heckel S, Favre R, Schlienger JL, Soskin P . Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves' disease. A case report. Fetal Diagn Ther 1997; 12 (1): 54–58.
Wenstrom KD, Weiner CP, Williamson RA, Grant SS . Prenatal diagnosis of fetal hyperthyroidism using funipuncture. Obstet Gynecol 1990; 76 (3, Part 2): 513–517.
Rivkees SA . Propylthiouracil versus methimazole during pregnancy: an evolving tale of difficult choices. J Clin Endocrinol Metab 2013; 98 (11): 4332–4335.
Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, Bernus I . Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997; 82 (9): 3099–3102.
Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N . Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 2007; 92 (6): 2157–2162.
Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, et al. The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 2009; 19 (7): 673–674.
Huel C, Guibourdenche J, Vuillard E, Ouahba J, Piketty M, Oury JF, et al. Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter. Ultrasound Obstet Gynecol 2009; 33 (4): 412–420.
Nachum Z, Rakover Y, Weiner E, Shalev E . Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol 2003; 189 (1): 159–165.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Sato, Y., Murata, M., Sasahara, J. et al. A case of fetal hyperthyroidism treated with maternal administration of methimazole. J Perinatol 34, 945–947 (2014). https://doi.org/10.1038/jp.2014.163
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2014.163